| Additional information |
| Colour |
Emerald Green, Royal Blue, Burnt Orange, Turquoise Teal, Mustard Yellow
|
|
| Colour |
Emerald Green, Royal Blue, Burnt Orange, Turquoise Teal, Mustard Yellow
|
|
| Colour |
Emerald Green, Royal Blue, Burnt Orange, Turquoise Teal, Mustard Yellow
|
|
| Colour |
Emerald Green, Royal Blue, Burnt Orange, Turquoise Teal, Mustard Yellow
|
|
| Colour |
Emerald Green, Royal Blue, Burnt Orange, Turquoise Teal, Mustard Yellow
|
|
| Colour |
Emerald Green, Royal Blue, Burnt Orange, Turquoise Teal, Mustard Yellow
|
|
| Description | Meno-Pause combines Ipamorelin and Sermorelin, two peptides that stimulate natural growth hormone production. This combination is designed to support women during menopause by improving energy, sleep, skin health, and overall wellbeing. | Semaglutide activates the GLP-1 (glucagon-like peptide-1) receptor, producing multiple downstream effects: enhanced insulin secretion in response to meals, suppressed glucagon output, delayed gastric emptying, and reduced appetite signals. | Unlock a leaner, sharper, and more youthful you with Peptide Pen’s 5-Amino-1MQ. This potent 100mg peptide pen delivers 5-Amino-1MQ, a cutting-edge compound that promotes fat loss, enhances cognitive function, and supports anti-aging. | Tirzepatide is a medication that has gained significant attention for its role in weight loss and managing metabolic conditions like type 2 diabetes. It works by mimicking two natural hormones in the body: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). These hormones help regulate blood sugar, control appetite, and support metabolic health. | Treats type 2 diabetes and aids in long-term weight management. | Melano Glow by Peptide Pen brings you skin radiance, elasticity, and natural pigmentation—all from the inside out. Powered by Melanotan II, this anti-aging peptide stimulates melanin production, enhancing your skin tone and UV resilience while promoting collagen health and longevity. |
Reviews
There are no reviews yet.